The White Mesa Mill, which hadn’t processed much uranium over the last 20 years, now plans to be open for the foreseeable ...
Scholar Rock Holding Corporation (SRRK), a late-stage biopharmaceutical company, Monday said its Phase 3 SAPPHIRE study evaluating ...
Scholar Rock Holding said that its treatment for spinal muscular atrophy met primary endpoint targets in a phase 3 clinical trial. The late-stage biopharmaceutical company said Monday that Apitegromab ...
Scholar Rock Holdings Corp.’s stock soared more than 200% early Monday, after the clinical-stage biotech said a late-stage ...
Scholar Rock said on Monday its experimental drug apitegromab met the main goal of a late-stage trial in patients with a type of rare genetic disease, sending the company's shares surging in premarket ...